Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 18586690)


Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells.

Streicher W, Luedeke M, Azoitei A, Zengerling F, Herweg A, Genze F, Schrader MG, Schrader AJ, Cronauer MV.

PLoS One. 2014 Jun 2;9(6):e98566. doi: 10.1371/journal.pone.0098566. eCollection 2014.


Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model.

Yatkin E, Polari L, Laajala TD, Smeds A, Eckerman C, Holmbom B, Saarinen NM, Aittokallio T, Mäkelä SI.

PLoS One. 2014 Apr 3;9(4):e93764. doi: 10.1371/journal.pone.0093764. eCollection 2014.


Resveratrol in prostate diseases - a short review.

Jasiński M, Jasińska L, Ogrodowczyk M.

Cent European J Urol. 2013;66(2):144-9. doi: 10.5173/ceju.2013.02.art8. Epub 2013 Aug 13. Review.


Resveratrol and cancer: focus on in vivo evidence.

Carter LG, D'Orazio JA, Pearson KJ.

Endocr Relat Cancer. 2014 May 6;21(3):R209-25. doi: 10.1530/ERC-13-0171. Print 2014 Jun. Review.


Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.

Sanna V, Siddiqui IA, Sechi M, Mukhtar H.

Mol Pharm. 2013 Oct 7;10(10):3871-81. doi: 10.1021/mp400342f. Epub 2013 Sep 4.


Resveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell development.

Peltz L, Gomez J, Marquez M, Alencastro F, Atashpanjeh N, Quang T, Bach T, Zhao Y.

PLoS One. 2012;7(5):e37162. doi: 10.1371/journal.pone.0037162. Epub 2012 May 16.


Dietary factors and epigenetic regulation for prostate cancer prevention.

Ho E, Beaver LM, Williams DE, Dashwood RH.

Adv Nutr. 2011 Nov;2(6):497-510. doi: 10.3945/an.111.001032. Epub 2011 Nov 3. Review.


Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment.

Hudson TS, Perkins SN, Hursting SD, Young HA, Kim YS, Wang TC, Wang TT.

Int J Oncol. 2012 Apr;40(4):1113-21. doi: 10.3892/ijo.2012.1335. Epub 2012 Jan 17.


A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death.

Freeman MR, Kim J, Lisanti MP, Di Vizio D.

Cancer Biol Ther. 2011 Dec 1;12(11):966-77. doi: 10.4161/cbt.12.11.18136. Epub 2011 Dec 1.


Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.

Johnson WD, Morrissey RL, Usborne AL, Kapetanovic I, Crowell JA, Muzzio M, McCormick DL.

Food Chem Toxicol. 2011 Dec;49(12):3319-27. doi: 10.1016/j.fct.2011.08.023. Epub 2011 Sep 10.


What is new for an old molecule? Systematic review and recommendations on the use of resveratrol.

Vang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, Das DK, Delmas D, Gottfried C, Lin HY, Ma QY, Mukhopadhyay P, Nalini N, Pezzuto JM, Richard T, Shukla Y, Surh YJ, Szekeres T, Szkudelski T, Walle T, Wu JM.

PLoS One. 2011;6(6):e19881. doi: 10.1371/journal.pone.0019881. Epub 2011 Jun 16. Review.


Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.

Kovacic P, Somanathan R.

Oxid Med Cell Longev. 2010 Mar-Apr;3(2):86-100. doi: 10.4161/oxim.3.2.11147. Review.


Resveratrol: Biological and pharmaceutical properties as anticancer molecule.

Hsieh TC, Wu JM.

Biofactors. 2010 Sep-Oct;36(5):360-9. doi: 10.1002/biof.105. Review.


Apoptosis by dietary agents for prevention and treatment of prostate cancer.

Khan N, Adhami VM, Mukhtar H.

Endocr Relat Cancer. 2010 Jan 29;17(1):R39-52. doi: 10.1677/ERC-09-0262. Print 2010 Mar. Review.


Repressive effects of resveratrol on androgen receptor transcriptional activity.

Shi WF, Leong M, Cho E, Farrell J, Chen HC, Tian J, Zhang D.

PLoS One. 2009 Oct 9;4(10):e7398. doi: 10.1371/journal.pone.0007398.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk